Repetitive sequences account for more than 50% of the human genome. Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal-dominant disease associated with reduction in the copy number of the D4Z4 repeat mapping to 4q35. By an unknown mechanism, D4Z4 deletion causes an epigenetic switch leading to de-repression of 4q35 genes. Here we show that the Polycomb group of epigenetic repressors targets D4Z4 in healthy subjects and that D4Z4 deletion is associated with reduced Polycomb silencing in FSHD patients. We identify DBE-T, a chromatin-associated noncoding RNA produced selectively in FSHD patients that coordinates de-repression of 4q35 genes. DBE-T recruits the Trithorax group protein Ash1L to the FSHD locus, driving histone H3 lysine 36 dimethylation, chromatin remodeling, and 4q35 gene transcription. This study provides insights into the biological function of repetitive sequences in regulating gene expression and shows how mutations of such elements can influence the progression of a human genetic disease.
INTRODUCTION
Facioscapulohumeral muscular dystrophy (FSHD) (MIM 158900) is one of the most common myopathies (Cabianca and Gabellini, 2010) . It is an autosomal-dominant disease characterized by progressive wasting of facial, upper arm, and shoulder girdle muscles. In up to 95% of cases, the genetic defect is mapped to the subtelomeric region of chromosome 4q35. Remarkably, FSHD patients do not carry a classical mutation within a protein-coding gene. FSHD is rather caused by deletions reducing the copy number of the 3.3 kb D4Z4 repeat below 11 units. D4Z4 is extremely polymorphic in the general population and belongs to a family of human noncentromerically located tandem repeats termed macrosatellites (Chadwick, 2009) . Several FSHD features, such as variability in severity and rate of progression, gender bias in penetrance, asymmetric muscle wasting, and monozygotic twin discordance, strongly suggest the involvement of epigenetic factors (Neguembor and Gabellini, 2010) . Accordingly, DNA methylation , histone marks (Bodega et al., 2009; Zeng et al., 2009) , and higher order chromatin structure (Bodega et al., 2009; Petrov et al., 2006; Pirozhkova et al., 2008) are altered in FSHD patients. These changes have been associated with the inappropriate de-repression of several 4q35 genes, among which DUX4 is currently the leading FSHD candidate (Gabellini et al., 2002; Lemmers et al., 2010) . However, the molecular mechanism underlying the epigenetic switch at the basis of FSHD is currently unknown.
Polycomb (PcG) and Trithorax (TrxG) group proteins act antagonistically in the epigenetic regulation of gene expression. Typically, TrxG counteracts PcG-mediated epigenetic gene silencing. PcG and TrxG factors play crucial roles in many biological aspects such as cell proliferation, stem cell identity, and X inactivation (Schuettengruber et al., 2007) . In Drosophila, PcG and TrxG bind to specific DNA regions termed Polycomb/ Trithorax response elements (PREs/TREs), constituting a regulated switchable element that influences chromatin architecture and expression of nearby genes (Ringrose and Paro, 2004; Schuettengruber et al., 2007) .
D4Z4 shares several features with PREs/TREs (Figure S1 available online). In healthy subjects, D4Z4 is organized as repressed chromatin and displays the PcG-associated histone mark H3K27me3 (histone H3 lysine 27 tri-methylation) (Bodega et al., 2009; Jiang et al., 2003; van Overveld et al., 2003; Zeng et al., 2009) . Interestingly, in FSHD patients loss of repressive marks and 4q35 genes de-repression has been reported (Bodega et al., 2009; Dixit et al., 2007; Gabellini et al., 2002; Rijkers et al., 2004) . Each D4Z4 unit contains copies of a motif nearly identical to a conserved sequence (CNGCCATNDNND) found in Drosophila PREs (Gabellini et al., 2002; Mihaly et al., 1998) . This sequence overlaps with DBE (D4Z4 binding element), a region necessary and sufficient to confer copy-number-dependent repressive activity (Gabellini et al., 2002) due to its ability to recruit YY1, EZH2, and HMGB2 (human homologs of the Drosophila PcG proteins Pho and E(z) and the PcG recruiter Dsp1, respectively) (Bodega et al., 2009; Dé jardin et al., 2005; Gabellini et al., 2002) . The region surrounding DBE is enriched in putative binding sites for GAGA factor (Gaf), a DNA-binding protein implicated in PRE function in Drosophila (Busturia et al., 2001; Mishra et al., 2001) . Finally, a role for CpG-rich regions in PcG recruitment in mammals has been suggested (Mendenhall et al., 2010) , and the region occupied by D4Z4 in healthy subjects is one of the biggest CpG islands of the human genome (Neguembor and Gabellini, 2010) .
In Drosophila, the TrxG protein Ash1 plays a crucial role in derepression of PcG targets (Beisel and Paro, 2011; Papp and Mü ller, 2006; Schwartz et al., 2010) and can be recruited by ncRNAs (Sanchez-Elsner et al., 2006) . Interestingly, ASH1L, the mammalian homolog of fly Ash1, was shown to occupy actively transcribed chromatin (Gregory et al., 2007) . However, the exact function of Ash1L and how it is recruited to its targets are poorly understood.
Here, we investigated the possibility that transcription of DBE regulates the epigenetic switch responsible for de-repression of the FSHD locus.
RESULTS

D4Z4 Recruits Polycomb Complexes to Repress 4q35
Genes By 3D fluorescence in situ hybridization (3D-FISH), the PcG hallmark H3K27me3 was shown to be reduced selectively on the contracted 4q35 allele in FSHD primary muscle cells (Bodega et al., 2009 ). This suggested that contraction of D4Z4 repeats could determine a loss of Polycomb silencing in FSHD. We used chromatin immunoprecipitation followed by real-time PCR (ChIP-qPCR) to analyze levels of EZH2 and H3K27me3 in primary muscle cells. In healthy subjects, EZH2 was enriched on the entire D4Z4 unit and on regions immediately proximal to the repeat array ( Figure 1B) , including an element that we called NDE (for nondeleted element) because it is always maintained in FSHD patients regardless of their type of deletion . H3K27me3 was also enriched on the same regions but showed a peak on NDE ( Figure 1C ). Intriguingly, in FSHD patients, D4Z4 deletion was associated with a significant reduction of EZH2 at the FSHD locus ( Figure 1B ) and this translated into a significant decrease of H3K27me3 on the regions immediately proximal to the repeat array, including NDE ( Figure 1C ).
We found that in healthy subjects EZH2 and H3K27me3 were enriched above background at the promoters of ANT1, FRG1, and FRG2, even though they were at lower levels than those in NDE ( Figures S2A and S2B ). In FSHD patients, a trend toward a reduction in EZH2 and H3K27me3 enrichment at 4q35 genes promoters was observed ( Figures S2A and S2B) .
The selective study of 4q-located D4Z4 repeats in human samples is challenged by the presence of D4Z4-like sequences on almost all human acrocentric chromosomes (Lyle et al., 1995; Winokur et al., 1994) . By sequencing the PCR products of our Polycomb ChIP-qPCRs performed on human samples, we did not find D4Z4-like sequences, suggesting that D4Z4-like repeats elsewhere in the genome are not associated with PcG binding.
Because D4Z4 is a primate-specific repeat (Clark et al., 1996) , genetic mouse models of FSHD (displaying for example a different number of D4Z4 repeats) cannot be generated. Nevertheless, we exploited the above limitation by using human/ rodent monochromosomal hybrid cells containing, in a CHO background, a single human chromosome 4 derived from a healthy subject (chr4/CHO). In this setting, the only D4Z4 source is the human chromosome 4. Importantly, we confirmed that human chr4/CHO cells display all the epigenetic features typically found at the FSHD locus in healthy subjects including DNA hypermethylation , histone hypoacetilation (Jiang et al., 2003) , enrichment of cohesin, HP1g and H3K9me3 (Zeng et al., 2009 ), and repression of 4q35 genes (C. Huichalaf and D. Gabellini, unpublished data) .
PcG proteins are found in several families of multiprotein complexes. The two main complexes are termed Polycomb Repressive Complex 1 and 2 (PRC1 and PRC2). In mammals, there are multiple versions of PRC1 and PRC2 due to the presence of many alternative subunits (Margueron and Reinberg, 2011) . We focused our analysis on core PRC1 and PRC2 components. By ChIP-qPCR in chr4/CHO cells, we found that the PRC1 components Bmi1, Rae28, and Ring1B are enriched on the entire D4Z4 unit and on NDE ( Figure S2D ). Intriguingly, the typical PRC1 repressive histone mark H2Aub1 (histone H2A monoubiquitinated on lysine 119) was enriched on the same regions but showed a peak on NDE ( Figure S2D ). For PRC2, we analyzed the core subunits Eed, Ezh2, and Suz12. Similarly to PRC1, PRC2 and its repressive mark, H3K27me3, were enriched over the entire FSHD locus ( Figure S2E ), with H3K27me3 showing a peak on NDE ( Figure S2E ).
Several proteins collaborate to recruit Polycomb to PREs (Margueron and Reinberg, 2011) . Interestingly, Figure S2F shows that two PcG recruiters, Jarid2 (Landeira and Fisher, 2011) and c-Krox/Th-POK (the putative vertebrate homolog of GAGA factor, Busturia et al., 2001; Matharu et al., 2010; Mishra et al., 2001) , were enriched at the FSHD locus. Furthermore, the repressive histone variant macroH2A, overlapping locally and functionally with PRC2 (Buschbeck et al., 2009) , was enriched at the FSHD locus ( Figure S2G ). Notably, ChIP-qPCR signals at D4Z4 were comparable to those observed on the bona fide PcG target Hoxd11 (Woo et al., 2010) 
One of the features of PREs is their ability to recruit PcG complexes when inserted in ectopic sites. To test this, we introduced in CHO cells human 4q35 bacterial artificial chromosomes (BACs) either containing or lacking D4Z4 repeats (Figure 1D) . To directly compare Polycomb recruitment, we performed ChIP-qPCR with primers mapping on the insert-flanking region common to both BACs. As shown in Figures 1E and 1F, we found robust recruitment for PRC1, PRC2, and their associated repressive histone marks selectively in the BAC-containing D4Z4 repeats. This result indicates that D4Z4 repeats are able to initiate de novo recruitment of Polycomb complexes.
Based on our results, we hypothesized that D4Z4 recruits Polycomb complexes to repress 4q35 genes. We tested this directly by performing RNAi-mediated loss of Polycomb. As shown in Figures 1G-1J , Suz12 knockdown caused a de-repression of 4q35 genes comparable to that of the bona fide Polycomb target gene Hoxd11.
Altogether, our results strongly suggest that loss of Polycomb silencing is responsible for de-repression of 4q35 genes in FSHD patients.
Transcription of DBE Occurs Selectively in FSHD Patients and Is Associated with 4q35 Gene De-Repression
It has been reported that transcription of ncRNAs from PREs could play a role in relief of PcG-mediated silencing in Drosophila (Bae et al., 2002; Lipshitz et al., 1987; Rank et al., 2002; Sanchez-Elsner et al., 2006; Schmitt et al., 2005) . Because of the similarities between DBE and PREs, we analyzed transcription from DBE ( Figure 1A ). We performed real-time RT-PCR (qRT-PCR) on total RNA extracted from muscle biopsies or primary muscle cells from healthy subjects and FSHD patients. Figure 2A shows that DBE was transcribed above background exclusively in FSHD samples to generate an RNA that we named DBE-T (DBE-Transcript). As stated above, D4Z4-like sequences are located on several human chromosomes (Lyle et al., 1995; Winokur et al., 1994) . To verify the chromosomal origin of DBE-T, we extensively sequenced the qRT-PCR products from muscle biopsies and primary muscle cells to take advantage of 4q35specific SNPs. Notably, 97% of the products were 4q35 specific, indicating that DBE-T originated from the FSHD-associated locus. To confirm this, we again took advantage of human chr4/CHO cells. In this system, the de-repression of 4q35 genes due to RNAi-mediated loss of Polycomb ( Figure 1J ) was associ-ated with DBE-T production ( Figure 2B ). We have recently found that DNA methylation and histone deacetylation are required for keeping the 4q35 region repressed (C. Huichalaf and D. Gabellini, unpublished data) . As a consequence, treatment with AZA (5-Aza-2 0 -deoxycytidine) plus TSA (Trichostatin A) (inhibitors of DNA methylation and histone de-acetylation, respectively) resulted in de-repression of 4q35 genes ( Figure 2C ). Intriguingly, also in this case 4q35 gene de-repression was paralleled by production of DBE-T ( Figure 2C) .
Several elements suggested that AZA plus TSA effects on the FSHD locus were fairly specific. Histone deacetylation has a role in PRC1-mediated chromatin compaction (Eskeland et al., 2010) and TSA treatment causes relief of Polycomb silencing (Garrick et al., 2008) . In chr4/CHO cells, AZA plus TSA treatment caused a dramatic de-repression of the bona fide PcG target Hoxd11, whereas the expression of the non-PcG target Gapdh was unaffected, suggesting that loss of PcG silencing was not due to unspecific effects of the treatment ( Figure 2D ). Finally, AZA treatment did not affect the number of D4Z4 repeats nor reduce PcG binding or H3K27me3 enrichment ( Figure S3 ).
DBE-T Regulates 4q35 Chromatin Structure and Gene De-Repression
As shown above, in independent systems DBE-T production is always associated with de-repression of 4q35 genes. To address its biological role, we generated chr4/CHO stable cells expressing a DBE-T shRNA or a control, nonsilencing shRNA. Remarkably, DBE-T knockdown prevented 4q35 gene derepression caused by AZA plus TSA, strongly suggesting a functional role for this transcript in the positive regulation of 4q35 gene expression ( Figure 3A) .
shRNAs can directly cause epigenetic changes by transcriptional gene silencing (TGS) (Turner and Morris, 2010) , raising the possibility that DBE-T shRNAs could cause TGS at the FSHD locus. Importantly, treatment with AZA plus TSA prevents TGS because it is strictly dependent on the activity of DNA methyltransferases and histone deacetylases (Morris et al., 2004; Turner and Morris, 2010) . Given that we investigated effects of DBE-T shRNAs in cells treated with AZA plus TSA, it was extremely unlikely that TGS could play a role in our findings. To further address this, we analyzed recruitment of Ago1, which is required for TGS (Kim et al., 2006) . We used ChIP-qPCR to monitor Ago1 recruitment on NDE, DBE, and b-actin, which is unaffected by treatment with DBE-T shRNAs, as control. As shown in Figure S4 , at all regions analyzed Ago1 displayed a very low enrichment that was unaltered by DBE-T shRNAs (Figure S4) . These results indicate that DBE-T shRNAs do not cause TGS but only posttranscriptional degradation of the intended target RNA.
It has been reported that a chromatin reorganization is associated with 4q35 gene de-repression (Bodega et al., 2009; Petrov et al., 2006; Pirozhkova et al., 2008) . In particular, chromatin conformation capture (3C) detected an interaction between D4Z4 and the promoter of the 4q35 gene FRG1 that is reduced in FSHD patients compared to controls (Bodega et al., 2009 ). We confirmed this interaction in chr4/CHO cells and found that it is reduced when DBE-T is produced and FRG1 is de-repressed ( Figure 3C , left, and Figure 2C) . Notably, DBE-T knockdown prevented the topological reorganization of the FSHD region characteristic of the de-repressed state (Figure 3C, right) . Thus, DBE-T is involved in the regulation of 4q35 higher order chromatin structure and is required for 4q35 gene de-repression.
DBE-T Functions in cis and Is Associated with the Chromatin of the FSHD Locus
To dissect the role of DBE-T in 4q35 gene de-repression, we asked whether DBE-T ectopic expression could be sufficient to de-repress 4q35 genes. To this aim, chr4/CHO cells were transiently transfected with a construct producing DBE-T. In qRT-PCR assays, DBE-T overexpression was unable to de-repress 4q35 genes in trans ( Figure S5) .
To further elucidate DBE-T mechanism of action, we investigated its subcellular localization by using independent approaches. First, through biochemical fractionation we found that DBE-T was nuclear and mainly chromatin-associated and behaved similarly to the chromatin-bound ncRNA Xist, whereas Figure S3 . the protein-coding mRNA Gapdh was preferentially enriched in the cytoplasm, as expected ( Figure 4A ). Next, we used sequential RNA/DNA FISH to investigate the exact location of DBE-T inside the nucleus. We first hybridized nondenatured cells with LNA oligonucleotides targeting DBE-T. Next, cells were denatured to allow for DNA detection and hybridized with DNA oligonucleotides, mapping to the D4Z4 repeat in order to visualize the 4q35 locus (schematized in Figure 4B ). As shown in Figure 4C , DBE-T and D4Z4 signals colocalized in 98.8% of the cells analyzed, indicating that DBE-T is specifically associated with the FSHD locus. Importantly, to derive this conclusion we carried out several controls. First, the DBE-T signal was absent in CHO cells lacking D4Z4 and strongly reduced by RNase A+T1 treatment in chr4/CHO cells ( Figure S6A ), proving that it corresponded to a specific RNA. Second, using actinomycin D (ActD), we showed that DBE-T is a mature RNA. In fact, actively transcribed genes generate nascent transcripts, appearing as nuclear dots in RNA FISH, which are exquisitely sensitive to ActD. Accordingly, b-actin nascent transcripts quickly disappeared upon ActD treatment. On the contrary, the RNA FISH signals corresponding to DBE-T were unaffected by ActD treat-ment, strongly indicating that they corresponded to mature RNAs ( Figure S6B ). Altogether, these results indicate that DBE-T is a mature transcript associated with the chromatin of the FSHD locus.
DBE-T Is a Long ncRNA Starting from the Region Immediately Proximal to the D4Z4 Repeat Array
NcRNAs greater than 200 nt in length have been shown to be involved in PcG/TrxG function (Margueron and Reinberg, 2011) . Interestingly, using either NDE-or DBE-specific probes in northern blot with polyA + RNA, we detected transcripts as large as 9.8 kb that were upregulated in the de-repressed state ( Figure S7B ). On the contrary, a DUX4-specific probe detected an 3 kb band (in line with the expected size of DUX4 mRNA) not present in the NDE and DBE northern blots ( Figure S7B ). Taking advantage of the experimental approach previously used for rapid amplification of cDNA ends (RACE) of DUX4 (Kowaljow et al., 2007) , we mapped the start of DBE-T upstream of NDE (position 4099 of accession number AF117653, Figure S7A ). This result was supported by several independent findings. First, we successfully amplified a single transcript spanning the 2.8 kb from NDE to DBE ( Figure S7C ). Second, RT-PCR with overlapping primers spanning the 3.4 kb from the DBE-T start to the end of the DBE of the first D4Z4 repeat supported a single AZA+TSA inducible long RNA ( Figure S7D ). Third, like DBE-T, the NDE transcript is transcribed selectively when 4q35 genes are de-repressed ( Figure S7E) , generates a chromatinassociated RNA ( Figure S7F ), is overexpressed in FSHD muscle cells compared to controls ( Figure S7G) , and is 4q specific. Accordingly, NDE stable knockdown in chr4/CHO cells impaired de-repression of 4q35 genes ( Figure S7H ). Finally, NDE and DBE-T expression was reduced by reciprocal knockdown (Figure S7I ).
Based on the above results, we propose that DBE-T is a long RNA containing both NDE and DBE. DBE-T is clearly distinct from the protein-coding DUX4 transcript encoded by D4Z4 considering: (1) the northern blot results; (2) that the primers used to analyze DBE-T ( Figure S7A ) are unable to detect DUX4; and (3) that DBE-T is proximal to D4Z4, whereas only the last, most distal D4Z4 repeat can produce a stable transcript encoding for DUX4 (Dixit et al., 2007; Lemmers et al., 2010) .
We believe DBE-T to be nonprotein coding. In fact, even though it contains open reading frames (ORFs) bigger than 100 amino acids, DBE-T is chromatin-associated, and it is generally accepted that protein synthesis occurs only in the cytoplasm (Dahlberg and Lund, 2004) . Additionally, DBE-T does not function in trans, arguing against a protein-coding function.
Collectively, our results strongly suggest that a long, chromatin-associated nonprotein-coding RNA (lncRNA) encompassing NDE and DBE regulates gene expression at 4q35.
DBE-T Directly Recruits the TrxG Protein Ash1L to De-Repress 4q35 Genes
Because ncRNAs were shown to recruit TrxG proteins to target genes (Bertani et al., 2011; Sanchez-Elsner et al., 2006; Wang et al., 2011) , we investigated TrxG recruitment to the FSHD locus. The TrxG proteins Chd7 and Mll1 were enriched at similar levels in the repressed and de-repressed states on NDE and DBE regions ( Figure 5A ). Importantly, our data on Mll1 occupancy parallel what was previously described for its fly homolog Trx, which can co-occupy repressed targets together with PcG proteins (Papp and Mü ller, 2006; Schuettengruber et al., 2009; Schwartz et al., 2010) . On the contrary, the TrxG protein Ash1L was preferentially enriched on NDE specifically in the derepressed state ( Figure 5A) . Interestingly, the recruitment of Ash1 is the main determinant that distinguishes the repressed from the de-repressed state in Drosophila as well (Papp and Mü ller, 2006; Schwartz et al., 2010) . Importantly, ChIP-qPCR assays showed that ASH1L is recruited to the FSHD locus preferentially in muscle cells from FSHD patients compared to those from healthy subjects ( Figure 5B ). Hence, we hypothesized that Ash1L might be involved in de-repression of 4q35 genes. To test this, we generated stable chr4/CHO cells expressing a nonsilencing (control shRNA) or an shRNA specific for Ash1L (shAsh1L). qRT-PCR, immunoblotting and ChIP-qPCR assays indicated that we only partially reduced Ash1L expression and recruitment to the FSHD locus ( Figures 5C-5E ). Nevertheless, this was sufficient to impair 4q35 gene de-repression ( Figure 5F ).
Based on our results, we speculated that DBE-T could play a role in the recruitment of Ash1L to the FSHD locus. To assess this, we performed RNA immunoprecipitation following ultraviolet crosslinking (UV-RIP) with anti-Ash1L antibodies or IgG, as control. DBE-T was significantly enriched in the Ash1L UV-RIP, whereas nonrelated nuclear RNAs such as the precursor of miR19A or the abundant U1 snRNA were not ( Figure 6A ). Because UV irradiation only identifies direct protein-nucleicacid interactions (Greenberg, 1979) , a direct Ash1L-DBE-T interaction in vivo was suggested. To confirm this, we performed in vitro pull-down experiments by using purified, recombinant GST-Ash1L and in vitro transcribed DBE-T. GST-Ash1L was able to directly interact with DBE-T, whereas no enrichment was obtained by using GST alone ( Figure 6B ). To investigate whether DBE-T is required for Ash1L recruitment to the FSHD locus, we performed Ash1L ChIP-qPCR in cells knockdown for DBE-T. DBE-T knockdown impaired the recruitment of Ash1L to the FSHD locus ( Figure 6C ). Collectively, our results strongly indicate that DBE-T functions in cis by directly recruiting Ash1L to the FSHD locus.
Ash1L is a histone methyltransferase, but there are conflicting reports regarding its enzymatic activity. In particular, the two activating histone marks, H3K4me3 (histone H3 lysine 4 trimethylation) and H3K36me2 (histone H3 lysine 36 di-methylation), have been ascribed to Ash1L (An et al., 2011; Gregory et al., Tanaka et al., 2007; Yuan et al., 2011) . By ChIP-qPCR, we found that both histone marks are increased in the de-repressed state at the FSHD locus ( Figure S8A ). Interestingly, Ash1L knockdown caused a decrease in H3K36me2, whereas H3K4me3 was unaffected ( Figure S8B ). Moreover, H3K36me2 was also decreased by DBE-T knockdown ( Figure S8C ).
H3K36me2 is also the product of the ordinary process of transcription elongation and does not require Ash1L (Krogan et al., 2003) . Although Ash1L and H3K36me2 were detectable above background levels at 4q35 gene promoters, de-repression of 4q35 genes was not associated with an increase in Ash1L or H3K36me2 at their genomic regions ( Figures S8D and S8E) . Thus, the increase in H3K36me2 observed at the FSHD locus in the de-repressed state was directly due to Ash1L recruitment. Intriguingly, we found that Ash1L positively regulated DBE-T, because DBE-T expression was reduced upon Ash1L knockdown ( Figure 6D ). Hence, DBE-T and ASH1L could potentially constitute a positive feedback loop that keeps the 4q35 region de-repressed upon D4Z4 deletion.
Altogether, our results indicate that DBE-T directly recruits ASH1L to the FSHD locus to co-ordinate 4q35 gene derepression.
DISCUSSION
Among the different types of muscle diseases, FSHD is undoubtedly one of the less characterized. Indeed, the molecular events leading to FSHD remain undeciphered (Cabianca and Gabellini, 2010) . Based on our results, we propose a model to explain the epigenetic basis of FSHD etiology. In healthy subjects, the presence of many D4Z4 units would result in extensive PcG binding, DNA methylation, histone de-acetylation, and chromatin compaction leading to a repressive chromatin organization (Figure 7) . We propose that PcG complexes are recruited first on D4Z4 repeats, and then silencing spreads on the region immediately proximal to the repeat array. In FSHD patients, deletion of D4Z4 repeats results in a critical reduction of PcG silencing, permissive for DBE-T transcription (Figure 7) . Once produced at sufficient levels, DBE-T recruits ASH1L, leading to 4q35 gene de-repression (Figure 7) . Importantly, we found that Ash1L promotes the expression of DBE-T, implying a positive feedback loop that would sustain 4q35 gene de-repression.
On chromosomal region 10q26 is located a repeat array almost identical and equally polymorphic to the 4q35 D4Z4 array (Bakker et al., 1995; Cacurri et al., 1998; Deidda et al., 1996) . Nevertheless, contraction of D4Z4 repeats on 10q26 is not pathogenic, and FSHD is uniquely linked to 4q35 (Cacurri et al., 1998; Lemmers et al., 1998) . It has been shown that H3K9me3 is coregulated on 4q35 and 10q26 D4Z4 repeats (Zeng et al., 2009) , implying that nonpathogenic 10q26 contraction should cause loss of H3K9me3 also on 4q35. This suggests that H3K9me3 loss is not directly involved in FSHD. On the contrary, PcG silencing and DNA methylation are reduced selectively at the deleted 4q35 allele in FSHD (Bodega et al., 2009; van Overveld et al., 2003) and better explain the strictly 4q35-linked nature of the disease.
The FSHD locus is epigenetically regulated during normal development. In particular, DUX4 is expressed in pluripotent stem cells and in normal development, and then epigenetically silenced in somatic tissues . Interestingly, DUX4 has been retained during primate evolution, suggesting that DUX4 might have a normal role in early embryonic muscle development Wu et al., 2010) . Accordingly, we hypothesize that the PcG/TrxG epigenetic regulation of the FSHD locus could be important in normal muscle biology.
Recent results indicate that RNAi of a single 4q35 gene in an FSHD animal model has a therapeutic value (Bortolanza et al., 2011; Wallace et al., 2011) . Nevertheless, the complexity of FSHD could be better explained by envisaging it as a contiguous gene syndrome, where the epigenetic alteration of DUX4, FRG1 and other genes collaborate to determine the final phenotype. Hence, instead of targeting the inappropriate expression of individual 4q35 genes, it could be more effective to target a general 4q35 genes' regulator. Based on our results, it is tempting to speculate that DBE-T is a valid therapeutic target to achieve a general normalization of 4q35 gene expression in FSHD.
In Drosophila, PREs were shown to generate ncRNAs that regulate the epigenetic status of the locus (Bae et al., 2002; Lipshitz et al., 1987; Petruk et al., 2006; Rank et al., 2002; Sanchez-Elsner et al., 2006; Schmitt et al., 2005) . Recently, the first example of an activatory lncRNA involved in de-repression of a mammalian PcG target has been provided (Wang et al., 2011) . Our results indicate that DBE-T acts directly as a chromatin-associated lncRNA to activate the epigenetic cascade culminating with 4q35 gene de-repression in FSHD. To the best of our knowledge, DBE-T is the first activatory lncRNA involved in a human genetic disease.
ASH1L occupies many active genes (Gregory et al., 2007) , and TrxG family proteins are involved in many cell fate decisions in development and disease (Mills, 2010; Smith et al., 2011) . Our findings suggest a general function for chromatin-associated lncRNAs in recruiting ASH1L or other chromatin-remodeling complexes to coordinate chromosome structure and gene expression.
A significant portion of the human genome is composed of macrosatellite repeats (Warburton et al., 2008) . Although once thought of primarily as ''junk,'' recent studies indicate that repeated elements play central roles in regulating gene expression at multiple levels (Faulkner et al., 2009; Kaneko et al., 2011; Norris et al., 1995; Shen et al., 2011) . Similarly to D4Z4, other repeats display meiotic instability associated with diseases (Bruce et al., 2009; Tremblay et al., 2010) , reside within common fragile sites that could contribute to chromosome rearrangements in tumors (Tremblay et al., 2010) , and are expressed at high levels in testis and aberrantly expressed in cancer (Gjerstorff and Ditzel, 2008; Ting et al., 2011; Tremblay et al., 2010) . Interestingly, in mammals the greatest proportion of PcG-mediated chromatin modifications is located in genomic repeats, and it has been suggested that they could provide a binding platform for PcG proteins . Hence, elucidating the role of these elements in setting up functional chromatin states in complex genomes will be of paramount importance in upcoming years.
EXPERIMENTAL PROCEDURES
Mammalian Cell Culture CHO, HEK293T, human primary muscle cells, and human chromosome 4/CHO hybrid (GM10115) culture, stable knockdown, and treatments with chemicals are described in the Extended Experimental Procedures.
Figure 7. Model for DBE-T-Mediated 4q35 Gene De-Repression in FSHD
Normal individuals carry multiple D4Z4 copies that are extensively bound by PcG proteins, promoting the maintenance of repressed chromatin at 4q35. In FSHD patients, D4Z4 deletion leads to insufficient binding of PcG, causing the production of DBE-T. DBE-T recruits the TrxG protein ASH1L and promotes a topological reorganization of the FSHD locus leading to de-repression of 4q35 genes.
RNA Extraction, RT-PCR, qRT-PCR, Northern Blotting, and RACE RNA fractionation, RNA extraction, reverse transcription, real-time PCR, northern blotting, and RACE are described in the Extended Experimental Procedures (DBE-T accession number is JQ639078).
RNA/DNA FISH RNA/DNA FISH was performed essentially as described in Custodio et al. (2006) . Probe sequences and experimental details are described in the Extended Experimental Procedures.
Chromatin Immunoprecipitation
Assays were performed with normal IgG or the indicated antibodies. Precipitated DNA was measured by qPCR. Primer sets and methods are described in the Extended Experimental Procedures.
RNA ImmunoPrecipitation
This assay was carried out mainly as described previously (Jeon and Lee, 2011) . The detailed method is described in the Extended Experimental Procedures.
In Vitro RNA Pull-down Assay Recombinant GST-fusion proteins were prepared as described previously (Tanaka et al., 2008) . In vitro RNA pull-down assay was essentially carried out as previously described (Jeon and Lee, 2011) . For a detailed protocol refer to the Extended Experimental Procedures.
Chromosome Conformation Capture
Chromosome Conformation Capture (3C) was performed essentially as described in Bodega et al. (2009) . Primer sequences and methods are described in the Extended Experimental Procedures.
Statistical Analyses
For EZH2 and H3K27me3 ChIP-qPCR in human samples, two-way repeatedmeasured ANOVA was used.
For RNA FISH, a two-tailed, paired, t test was used.
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